FDA approves Adempas to treat pulmonary hypertension

Pulmonary hypertension-associated vasculitis

FDA approves Adempas to treat pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas to treat adults with two forms of pulmonary hypertension. According to Mayo Clinic, pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of your heart. It is a serious illness that becomes progressively worse and is sometimes fatal. Although pulmonary hypertension isn’t curable, treatments are available that can help lessen symptoms and improve your quality of life. Visit http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm370866.htm for more information about Adempas.

This entry was posted in Health and Beauty, Medication and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s